Prof Mattias Duytschaever from Bruges, Belgium, closed the 16th Atrial Fibrillation Symposium by thanking the presenters and attendees for the fruitful discussions, and interactive and insightful learning.
“We’ve had two exciting, fascinating days of research, a mixture of basic and clinical electrophysiology of atrial fibrillation with these very interactive and dynamic panel discussions,” he said. “It is clear that there are large gaps in the evidence regarding treatment of persistent or permanent atrial fibrillation, or whatever ‘P’ you use in your taxonomy. We still have to go a long way in persistent, permanent atrial fibrillation. For me, it’s clear that we need advanced, electroanatomical mapping. But I do believe that we are closing the gap towards durable PVI.”
Prof Duytschaever thanked Biosense Webster for their continuing efforts to improve catheter ablation, support of trials, and commitment to education that moves the field forward. He thanked his colleagues on the planning committee, Prof Mark O’Neill from London, UK, and Prof Dipen Shah of Geneva, Switzerland.
“We hope to see you next year for the 2018 Atrial Fibrillation Symposium, on 7–9 February in Prague,” he concluded.